MMED MiniMed Group, Inc.
$22.21▲ +1.09%
Healthcare
Other
Volume 812.3K
Avg Volume (10D) 2.91M
Key Metrics & Fundamentals
Market Cap
$6.25B
P/E Ratio
–
Div Yield
–%
52W Range
10.65 - 24.43
% vs 50 MA
15.94%
% vs 200 MA
–%
RSI-14
58.5
MACD Histogram
-0.0400
Beta (1Y vs SPY)
0.94
Free Cash Flow
-$90.00M
Gross Rev
$843.00M
Gross Profit
$465.00M
EBITDA
$41.00M
COGS
$378.00M
Operating Exp
$463.00M
Operating Income
$2.00M
EBIT
$2.00M
Pretax Income
$4.00M
Net Income
$0
EPS (Diluted)
0.00
Price & Volume History
Loading chart…
Recent News
MiniMed Files S-4 as Medtronic Seeks to Exit Remaining Stake
MT Newswires · Sep 14, 2026 12:09 PM
MiniMed Files Form S-4 Registration Statement in Connection with Medtronic Exchange Offer Announcement
PR Newswire · Sep 14, 2026 11:30 AM
Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
PR Newswire · Sep 14, 2026 11:30 AM
MiniMed’s (MMED) New Pump Lineup Is Finally Winning Patients Over
Insider Monkey · Sep 11, 2026 2:11 AM
MiniMed (MMED) Q1 2027 Earnings Call Transcript
Motley Fool · Sep 8, 2026 11:44 AM
Why MiniMed Stock Was Soaring This Week
Motley Fool · Sep 4, 2026 4:16 AM
MiniMed Group (MMED) Starts Fiscal 2027 Strong As Product And Regulatory Progress Builds
Simply Wall St. · Sep 3, 2026 4:16 PM
UBS Raises Price Target on MiniMed to $28 From $25, Keeps Buy Rating
MT Newswires · Sep 2, 2026 12:03 PM
Deutsche Bank Raises Price Target on MiniMed to $25 From $20, Keeps Buy Rating
MT Newswires · Sep 2, 2026 11:39 AM
Company News for Sep 2, 2026
Zacks · Sep 2, 2026 10:10 AM
Financial Overview - Income Statement
Quarterly
Jul 2026
See MMED's money flow as a full page
Social Sentiment
No Reddit posts found for MMED.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.